Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer

Daniela Massihnia, Elisa Giovannetti|Journal of Hematology & Oncology|2017

Cited by 84